Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
HOME
·
GF CSI Innovative Drugs Industry ETF
GF CSI Innovative Drugs Industry ETF(515120) Falls 0.79% in Morning Trading, Attracting RMB 459 Million Over Past 4 Days
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-04-20
GF CSI Innovative Drugs Industry ETF (515120) Rises 3.42% in Early Trading; Institutions: Leading Pharmaceutical Companies Have Successfully Navigated Centralized Procurement Cycle, Entering Innovation Harvest Period
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-04-01
BD Transaction Volume Exceeds $60 Billion in First Three Months; GF CSI Innovative Drugs Industry ETF (515120) Rises 1.63% in Early Trading, Targeting Third Consecutive Gain
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-03-31
GF CSI Innovative Drugs Industry ETF (515120) Rises 0.49% Against Market Trend; Multiple Biomedical Companies Post Strong Earnings Performance
Tags:
ETF
515120.SH
GF CSI Innovative Drugs Industry ETF
2026-03-30
GF CSI Innovative Drugs Industry ETF(515120) Rises 2.74% Intraday,Institutions Say the Sector’s Fundamentals Remain Sound
Tags:
ETF
GF CSI Innovative Drugs Industry ETF
515120.SH
2026-03-06
Previous
1
2
Featured News
Finance
SHENYANG PUBLIC (00747.HK): Disposes of 100% Equity Interest in Target Company for RMB 2 Million, Expects Gain of About RMB 33.55 Million
Finance
SF INTRA-CITY (09699.HK): Non-Executive Director Lei Yanqun Resigns
Finance
NEWLINK TECH (09600.HK): Termination of Memorandum of Intent on Equity Acquisition; Proposed Acquisition Will Not Proceed
Finance
LANCANG TEA (06911.HK): Subsidiary's RMB 24.9 Million Working Capital Loan Extended by One Year, Company Continues to Provide Guarantee
Overseas
Going Global Weekly: Mainland Companies Flock to Hong Kong Listings, Pharma Globalisation Shifts to Data and Capability Export-20260918
Finance
TRANSTHERA-B (02617.HK): Tinengotinib Included in CSCO Guidelines for Biliary Tract Malignancies (2026)
Finance
IMAGI INT'L (00585.HK): Change of Audit Committee Chairman — Tam Man Hong Succeeds Miao Xi
Finance
IMPACT THERAP-B (07630.HK): Sepalna Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Ovarian Cancer
Finance
CISI FIN (06058.HK): Discloseable Transaction — Subsidiary Disposes of USD 20.15 Million Notes, Recording a Gain of About USD 165,407
Finance
S HARBOURHOLD (01663.HK): Chairman and Substantial Shareholder Wang Linbing Acquires 3.89 Million Shares at Average Price of About HKD 0.056
Scan QR Code
Download App